Title : Dipeptidyl peptidase-4 inhibitors as a third-line oral antihyperglycaemic agent in patients with type 2 diabetes mellitus: the impact of ethnicity.

Pub. Date : 2014

PMID : 25180036






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The aim of this study is to examine the efficacy of adding a dipeptidyl peptidase-4 (DPP-4) inhibitor to patients with type 2 diabetes inadequately controlled by metformin and sulphonylurea combination treatment. Metformin dipeptidyl peptidase 4 Homo sapiens
2 The aim of this study is to examine the efficacy of adding a dipeptidyl peptidase-4 (DPP-4) inhibitor to patients with type 2 diabetes inadequately controlled by metformin and sulphonylurea combination treatment. Metformin dipeptidyl peptidase 4 Homo sapiens
3 DPP-4 inhibitor as a third-line add-on therapy can achieve significant glycaemic improvement in patients with type 2 diabetes inadequately controlled on the combination of metformin and sulphonylurea. Metformin dipeptidyl peptidase 4 Homo sapiens